201 related articles for article (PubMed ID: 21841856)
1. Pharmacologic management of arrhythmias.
Ganjehei L; Massumi A; Nazeri A; Razavi M
Tex Heart Inst J; 2011; 38(4):344-9. PubMed ID: 21841856
[No Abstract] [Full Text] [Related]
2. Ranolazine in Cardiac Arrhythmia.
Saad M; Mahmoud A; Elgendy IY; Richard Conti C
Clin Cardiol; 2016 Mar; 39(3):170-8. PubMed ID: 26459200
[TBL] [Abstract][Full Text] [Related]
3. Modulation of spiral wave reentry by K(+) channel blockade.
Honjo H; Yamazaki M; Kamiya K; Kodama I
Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
[TBL] [Abstract][Full Text] [Related]
4. Cardiac arrhythmogenesis: a tale of two clocks?
Lei M; Huang CL
Cardiovasc Res; 2020 Dec; 116(14):e205-e209. PubMed ID: 31800017
[No Abstract] [Full Text] [Related]
5. The antiarrhythmic effects of ranolazine.
Foster NJ; Haines DE
Rev Cardiovasc Med; 2009; 10 Suppl 1():S38-45. PubMed ID: 19898287
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological activation of IKr impairs conduction in guinea pig hearts.
Larsen AP; Olesen SP; Grunnet M; Poelzing S
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):923-9. PubMed ID: 20163495
[TBL] [Abstract][Full Text] [Related]
7. Safe and effective pharmacologic management of arrhythmias.
Razavi M
Tex Heart Inst J; 2005; 32(2):209-11. PubMed ID: 16107117
[No Abstract] [Full Text] [Related]
8. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
Sulimov VA
Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
[No Abstract] [Full Text] [Related]
9. The Relentless Pursuit of New Drugs to Treat Cardiac Arrhythmias.
Kowey PR; Robinson VM
Circulation; 2020 May; 141(19):1507-1509. PubMed ID: 32392105
[No Abstract] [Full Text] [Related]
10. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
Anderson ME
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
[No Abstract] [Full Text] [Related]
11. Modernized Classification of Cardiac Antiarrhythmic Drugs.
Lei M; Wu L; Terrar DA; Huang CL
Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
[TBL] [Abstract][Full Text] [Related]
12. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
Nattel S; Dobrev D
J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
[No Abstract] [Full Text] [Related]
13. Postrepolarization refractoriness in acute ischemia and after antiarrhythmic drug administration: action potential duration is not always an index of the refractory period.
Coronel R; Janse MJ; Opthof T; Wilde AA; Taggart P
Heart Rhythm; 2012 Jun; 9(6):977-82. PubMed ID: 22293142
[TBL] [Abstract][Full Text] [Related]
14. Use-dependent modulation of myocardial conduction by a new class of HERG agonists: deal breaker or cherry on top?
Akar FG
J Cardiovasc Electrophysiol; 2010 Aug; 21(8):930-2. PubMed ID: 20367661
[No Abstract] [Full Text] [Related]
15. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
Schmitt N; Grunnet M; Olesen SP
Physiol Rev; 2014 Apr; 94(2):609-53. PubMed ID: 24692356
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic drugs in pregnancy.
Joglar JA; Page RL
Curr Opin Cardiol; 2001 Jan; 16(1):40-5. PubMed ID: 11124717
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
Skibsbye L; Ravens U
Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
[TBL] [Abstract][Full Text] [Related]
18. Calcium overload, spontaneous calcium release, and ventricular arrhythmias.
Sipido KR
Heart Rhythm; 2006 Aug; 3(8):977-9. PubMed ID: 16876751
[No Abstract] [Full Text] [Related]
19. Letter to the editor on NaV1.8.
Numann RE; Gibson JK
Circ Res; 2012 Sep; 111(8):e230; author reply e231. PubMed ID: 23023513
[No Abstract] [Full Text] [Related]
20. Pharmacologic therapy of arrhythmias.
Naccarelli GV; Rinkenberger RL; Dougherty AH; Berns E; Crandell JR
Hosp Pract (Off Ed); 1988 Oct; 23(10):183-7, 190-2, 194-5 passim. PubMed ID: 3139691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
